Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 248-253

  Marcus, David L ^a   Freedman, Michael L ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLUCOSE PHOSPHATE; HEXOKINASE;

ADULT; AGED; ALZHEIMER DISEASE; AUTOPSY; BRAIN METABOLISM; BRAIN MICROCIRCULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME KINETICS; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; OXIDATIVE PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY;

EID: 0030700388     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48476.x     Document Type: Conference Paper

References (32)

1. KATZMAN, R. 1986. Alzheimer's disease. N. Engl. J. Med. 313: 964-973.
2. DAVIES, P. 1979. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171: 319-327.
3. ROSSOR, M. & C. Q. MOUNTJOY. 1986. Postmortem neurochemical changes in Alzheimer's disease compared with normal aging. Can. J. Neurol. Sci. 13: 499-502.
4. BENSON, D. F., D. E. KUHL, M. E. PHELPS et al. 1983. The fluorodeoxy-glucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch. Neurol. 40: 711-714.
5. DE LEON, M. J., S. H. FERRIS, A. E. GEORGE et al. 1983. Positron emission tomography studies of aging and Alzheimer's disease. Am. J. NR. 4: 568-571.
6. CHASE, T. N., P. FEDIO, N. L. FOSTER et al. 1984. Wechsler Adult Intelligence Scale performance: Cortical localization by fluorodeoxyglucose F18-positron emission tomography. Arch. Neurol. 41: 1244-1247.
7. FOSTER, N. L., T. N. CHASE, L. MANSI et al. 1984. Cortical abnormalities in Alzheimer's disease. Ann Neurol. 16: 649-654.
8. CUTLER, N. R., J. V. HAXBY, R. DUARA et al. 1985. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann. Neurol. 18: 298-309.
9. DUARA, R., C. GRADY, J. HAXBY et al. 1986. Positron emission tomography in Alzheimer's disease. Neurology 36: 879-887.
10. MCGEER, P. L., H. KAMO, R. HARROP et al. 1986. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. Can. Med. Assoc. J. 134: 597-607.
11. MEIER-RUGE, W. 1982. Neurochemistry of the aging brain and senile dementia. In Aging 2000: Our Health Care Destiny. C. M. Gaits and T. Samorajski, Eds. Springer Verlag, New York.
12. SIMS, N. R., J. P. BLASS, C. MURPHY et al. 1987. Phosphofructokinase activity in the brain in Alzheimer's disease. Ann. Neurol. 21: 509-510.
13. MCKHANN, G., D. DRACHMAN, M. HOLSTEIN et al. 1984. Clinical diagnosis of Alzheimer's disease. Neurology 34: 939-944.
14. REISBERG, B., S. H. FERRIS, M. J. DE LEON & T. CROOK. 1982. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychol. 139: 1136-1139.
15. REIVICH, M., A. ALAVI, A. WOLF et al. 1985. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J. Cereb. Blood Flow Metab. 5: 179-192.
16. MRSULJA, B. B., B. J. MRUSULJA, T. FUJIMOTO et al. 1976. Isolation of brain capillaries: A simplified technique. Brain Res. 110: 361-365.
17. BETZ, A .L., J. CSEJTY & G. W. GOLDSTEIN. 1979. Hexose transport and phosphorylation by capillaries isolated from rat brain. Am. J. Physiol. 236: C96-C102.
18. FORNAINI, G., M. DACHA, M. MAGNANI & M. STOCCHI. 1982. Hexokinase. Meth. Enzymol. 90: 3-10.
19. SWERDLOW, R., D. L. MARCUS, J. LANDMAN & M. L. FREEDMAN. 1994. Brain glucose metabolism in patients with Alzheimer's disease. Am. J. Med. Sci. 308: 141-144.
20. MARCUS, D. L., M. J. DELEON, J. GOLDMAN et al. 1989. Altered glucose metabolism from patients with Alzheimer's disease. Ann. Neurol. 26: 91-94.
21. PIERT, M., R. KOEPPE, B. GIORDANO et al. 1996. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J. Nucl. Med. 37: 201-208.
22. KALARIA, J. & S. HARIK. 1989. Reduced glucose transporter at the blood brain barrier and in the cerebral cortex in Alzheimer's disease. J. Neurochem. 53: 1083-1088.
23. SIMPSON, S., K. CHUNDU, T. DAVIES-HILL et al. 1994. Decreased concentrations of GLUT1 and GLUTS glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35: 546-551.
24. PARDRIDGE, W. 1994. Glucose transport and phosphorylation: Which is rate limiting for brain glucose utilization? Ann. Neurol. 35: 511-512.
25. WHITESELL, R., M. WARD, A. MCCALL et al. 1994. Coupled glucose transport and metabolism in cultured neuronal cells: Determination of the rate limiting step. J. Cereb. Blood Flow Metab. 15: 814-826.
26. HARA, M., Y. MATSUDA & H. NAKAGAWA. 1987. Molecular characteristics of the rat brain glucose transporter. J. Biochem. (Tokyo) 101: 43-52.
27. PARDRIDGE, W. & R. BORADO. 1993. Molecular cloning and regulation of gene expression of the blood-brain barrier glucose transporter. In The Blood Brain Barrier: Cellular and Molecular Biology. W. Pardridge, Ed.: 396-440. Raven Press, New York.
28. MEIER-RUGE, W., P. IWANOFF & K. REICHLMEIER. 1984. Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch. Gerontol. Geriatr. 3: 161-165.
29. DE LEON, M. J., A. E. GEORGE, S. H. FERRIS et al. 1984. Positron emission tomography and computed tomography assessments of the aging human brain. J. Comp. Asst. Tomogr. 8: 88-94.
30. MILLER, J., M. J. DE LEON, S. H. FERRIS et al. 1987. Abnormal temporal lobe response in Alzheimer's disease cognitive processing as measured by 11C-2-deoxy-D-glucose (11C-2-DG) and PET. J. Cereb. Blood How Metabol. 7: 248-251.
31. HAWKINS, R. A., J. C. MAZZIOTA, M. E. PHELPS et al. 1983. Cerebral glucose metabolism as a function of age in man: Influence of the rate constants in the fluorodeoxyglucose method. J. Cereb. Blood Flow Metabol. 3: 250-253.
32. RAPPORT, S. I., R. DUARA, E. D. LONDON et al. 1983. Glucose metabolism of the aging nervous system. Aging 22: 111-121.